The revision of the pharmaceutical legislation - it is time to act for nuclear medicine in Europe.

Eur J Nucl Med Mol Imaging

Department of Targetry, Target Chemistry and Radiopharmacy, Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.

Published: December 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684671PMC
http://dx.doi.org/10.1007/s00259-023-06472-1DOI Listing

Publication Analysis

Top Keywords

revision pharmaceutical
4
pharmaceutical legislation
4
legislation time
4
time nuclear
4
nuclear medicine
4
medicine europe
4
revision
1
legislation
1
time
1
nuclear
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!